Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cell Stem Cell|February 4, 2018
Meddling with METTLs in Normal and Leukemia Stem CellsGaëlle H Martin, Christopher Y Park
Immunology Letters|December 3, 2014
Potential limitations of IL-2 administration for the treatment of experimental acute graft-versus-host diseaseLouis Pérol, Gaëlle H Martin, Sébastien Maury, et al.
European Journal of Immunology|June 15, 2013
In vivo activation of transferred regulatory T cells specific for third-party exogenous antigen controls GVH disease in miceGaëlle H Martin, Sylvie Grégoire, Dan A Landau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2025
Characterization of human lung immune cells in the humanized BRGSF mouse modelDeepak Pokhreal, Anna V Curioni, Florent Creusat, et al.
Blood|August 11, 2016
Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cellsMathieu Leclerc, Sina Naserian, Caroline Pilon, et al.
The Journal of Clinical Investigation|November 25, 2010
Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting TregsYenkel Grinberg-Bleyer, David Saadoun, Audrey Baeyens, et al.
Brain, Behavior, and Immunity|December 9, 2014
Immunoendocrine dysbalance during uncontrolled T. cruzi infection is associated with the acquisition of a Th-1-like phenotype by Foxp3(+) T cellsFlorencia B González, Silvina R Villar, Rodrigo Fernández Bussy, et al.
The Journal of Experimental Medicine|August 3, 2019
CD97 is a critical regulator of acute myeloid leukemia stem cell functionGaëlle H Martin, Nainita Roy, Sohini Chakraborty, et al.
Frontiers in Immunology|February 22, 2024
Myeloid and dendritic cells enhance therapeutics-induced cytokine release syndrome features in humanized BRGSF-HIS preclinical modelGaëlle H Martin, Alexis Gonon, Perrine Martin-Jeantet, et al.
Frontiers in Immunology|October 3, 2025
Tumor-dependent myeloid and lymphoid cell recruitment in genO-BRGSF-HIS mice: a novel tool for evaluating immunotherapiesGaëlle H Martin, Siham Hedir, Florent Creusat, et al.
Pageof 2